Related Experiment Video
Updated: Mar 8, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Poor medication adherence in clinical trials: consequences and solutions
Alasdair Breckenridge1, Jeffrey K Aronson2, Terrence F Blaschke3
1Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3BX, UK.
Abstract:
Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this article, we highlight such consequences and also discuss approaches to tackle this problem.
More Related Videos
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Drug Therapy
Antianxiety Medications
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Dosing: Geriatric Patients
Therapeutic Drug Monitoring: Affecting Factors
Bioavailability Study Design: Healthy Subjects Versus Patients
Drug Toxicity: Risk factors